Présentations scientifiques

Expanding the Scope of Multiplex Engineering for Superior Generation of Efficient CAR T-cells - ASGCT 2023 - Présentation Poster

Télécharger le PDF

AMELI 01: A Phase I Trial of UCART123v1.2, an Anti CD123 Allogeneic CAR T Cell Product, in Adult Patients with Relapsed or Refractory (R/R) CD123+ Acute Myeloid Leukemia - ASGCT 2023 - Présentation orale

Télécharger le PDF

Deciphering the benefits of variable delivery routes and molecular armoring to enhance efficacy of MUC1-CAR T-cells in targeting triple-negative breast cancer - AACR 2023 - Présentation poster

Télécharger le PDF

AMELI-01:Preliminary Results from A Phase I Trial of UCART123v1.2, an Anti-CD123 Allogeneic CAR-T Cell Product, in Adult Patients with Relapsed or Refractory (R/R) CD123+ Acute Myeloid Leukemia - ASH 2022 - Présentation orale

Télécharger le PDF

Preclinical Activity of Allogeneic CS1-Specific CAR T-Cells (UCARTCS1) in Multiple Myeloma - ASH 2022 - Présentation poster

Télécharger le PDF

UCART20x22: First allogeneic dual CAR T-cell therapy for the treatment of B-cell malignancies - AACR 2022 - Abstract

Télécharger le PDF

UCART20x22: First allogeneic dual CAR T-cell therapy for the treatment of B-cell malignancies - AACR 2022 - Poster Presentation

Télécharger le PDF

Preclinical development of a TALEN-based genome editing in T cells for the treatment of Hyper-IgE-Syndrome - ESGCT 2021- Oral Presentation

Télécharger le PDF